β1-Adrenergic Receptor Polymorphisms: A Possible Genetic Predictor of Bisoprolol Response in Acute Coronary Syndrome

References

• ParkS , RheeM-Y , LeeSYet al.A prospective, randomized, open-label, active-controlled, clinical trial to assess central haemodynamic effects of bisoprolol and atenolol in hypertensive patients. J. Hypertens31(4), 813–819 (2013).
   PubMed Web of Science ®Google Scholar
• O'garaPT , KushnerFG , AscheimDDet al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol.61(4), e78–e140 (2013).
   PubMed Web of Science ®Google Scholar
• AmsterdamEA , WengerNK , BrindisRGet al.2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol.64(24), e139–e228 (2014).
   PubMed Web of Science ®Google Scholar
• SmallKM , McgrawDW , LiggettSB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol.43, 381–411 (2003).
   PubMed Web of Science ®Google Scholar
• RathzDA , GregoryKN , FangY , BrownKM , LiggettSB. Hierarchy of polymorphic variation and desensitization permutations relative to β1-and β2-adrenergic receptor signaling. J. Biol. Chem.278(12), 10784–10789 (2003).
   PubMed Web of Science ®Google Scholar
• MartiniJS , RaakeP , VingeLEet al.Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc. Natl Acad. Sci. U.S.A.105(34), 12457–12462 (2008).
   PubMed Web of Science ®Google Scholar
• JosephS , LynhamJ , GraceA , ColledgeW , KaumannA. Markedly reduced effects of (‐)‐isoprenaline but not of (‐)‐CGP12177 and unchanged affinity of β‐blockers at Gly389‐β1‐adrenoceptors compared to Arg389‐β1‐adrenoceptors. Br. J. Pharmacol.142(1), 51–56 (2004).
   PubMed Web of Science ®Google Scholar
• RathzDA , BrownKM , KramerLA , LiggettSB. Amino acid 49 polymorphisms of the human β 1-adrenergic receptor affect agonist-promoted trafficking. J. Cardiovasc. Pharmacol.39(2), 155–160 (2002).
   PubMed Web of Science ®Google Scholar
• LevinMC , MarulloS , MuntanerO , AnderssonB , MagnussonY. The myocardium-protective Gly-49 variant of the β1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J. Biol. Chem.277(34), 30429–30435 (2002).
   PubMed Web of Science ®Google Scholar
• JohnsonJ , LiggettS. Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions. Clin. Pharmacol. Ther.89(3), 366–378 (2011).
   PubMed Web of Science ®Google Scholar
• AzumaJ , NonenS. Chronic heart failure: β-blockers and pharmacogenetics. Eur. J. Clin. Pharmacol.65(1), 3–17 (2009).
   PubMed Web of Science ®Google Scholar
• RemmlerC , CascorbiI. Pharmacogenomics in acute coronary syndrome. Expert Opin. Pharmacother.9(3), 363–376 (2008).
   PubMed Web of Science ®Google Scholar
• IwaiC , AkitaH , KanazawaKet al.Arg389Gly polymorphism of the human β1-adrenergic receptor in patients with nonfatal acute myocardial infarction. Am. Heart J.146(1), 106–109 (2003).
   PubMed Web of Science ®Google Scholar
• PacanowskiMA , ZinehI , LiHet al.Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. J. Transl. Med.6(1), 1–11 (2008).
   PubMedGoogle Scholar
• El-MenyarA , RizkNM , AsimM , Al-ThaniH , ElgendyA , Al-SuwaidiJ. Association of β-Adrenergic Receptor Gene Polymorphisms with Acute Coronary Syndrome and Cardiovascular Risk Factors in an Arab Population. Angiology67(8), 762–771 (2016).
   PubMed Web of Science ®Google Scholar
• PacanowskiM , GongY , Cooper‐DehoffRet al.β‐adrenergic receptor gene polymorphisms and β‐blocker treatment outcomes in hypertension. Clin. Pharmacol. Ther.84(6), 715–721 (2008).
   PubMed Web of Science ®Google Scholar
• LewingtonS , ClarkeR , QizilbashN , PetoR , CollinsR. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet360(9349), 1903–1913 (2002).
   PubMed Web of Science ®Google Scholar
• JohnsonJA , ZinehI , PuckettBJ , McgorraySP , YarandiHN , PaulyDF. β1‐Adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin. Pharmacol. Ther.74(1), 44–52 (2003).
   PubMed Web of Science ®Google Scholar
• LiuJ , LiuZQ , TanZRet al.Gly389Arg polymorphism of β1‐adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin. Pharmacol. Ther.74(4), 372–379 (2003).
   PubMed Web of Science ®Google Scholar
• LiuJ , LiuZQ , YuBNet al.β1‐Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. Clin. Pharmacol. Ther.80(1), 23–32 (2006).
   PubMed Web of Science ®Google Scholar
• SiD , WangJ , XuY , ChenX , ZhangM , ZhouH. Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol. J. Cardiovasc. Pharmacol.64(4), 306–309 (2014).
   PubMed Web of Science ®Google Scholar
• Castaño-AmoresC , Díaz-VillamarínX , Pérez-GutiérrezAMet al.Pharmacogenetic polymorphisms affecting bisoprolol response. Biomed. Pharmacother.142, 112069 (2021).
   PubMed Web of Science ®Google Scholar
• LupoliS , SalviE , BarcellaM , BarlassinaC. Pharmacogenomics considerations in the control of hypertension. Pharmacogenomics16(17), 1951–1964 (2015).
   PubMed Web of Science ®Google Scholar
• FragosoJM , Rodríguez-PérezJM , Pérez-VielmaN , Martínez-RodríguezN , Vargas-AlarcónG. Beta1 adrenergic receptor polymorphisms Arg389Gly and Ser49Gly in the Amerindian and Mestizo populations of Mexico. Hum. Biol.77(4), 515–520 (2005).
   PubMed Web of Science ®Google Scholar
• LiuZQ , LiuJ , XiangZHet al.Distributive characteristics of Ser49Gly and Gly389Arg genetic polymorphisms of beta1-adrenoceptor in Chinese Han and Dai populations. Acta Pharmacol. Sin.27(2), 254–258 (2006).
   PubMed Web of Science ®Google Scholar
• WoodAJ , ZhouHH. Ethnic differences in drug disposition and responsiveness. Clin. Pharmacokinet.20(5), 350–373 (1991).
   PubMed Web of Science ®Google Scholar
• BioloA , ClausellN , SantosKGet al.Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy. Am. J. Cardiol.102(6), 726–732 (2008).
   PubMed Web of Science ®Google Scholar
• AutonA , BrooksLD , DurbinRMet al.A global reference for human genetic variation. Nature526(7571), 68–74 (2015).
   PubMed Web of Science ®Google Scholar
• ElGindy DM , SolaymanMH , KhorshidR , SchaalanMF , ElWakeel LM. Effect of Clinical and Genetic Factors on the Development of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG) in Egyptian Patients Receiving Beta-Blockers. Cardiovasc. Drugs Ther.1–10 (2022).
   Web of Science ®Google Scholar
• BelferI , BuzasB , EvansCet al.Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African Americans. Eur. J. Hum. Genet.13(3), 341–351 (2005).
   PubMed Web of Science ®Google Scholar
• LinnéY , DahlmanI , HoffstedtJ. beta1-Adrenoceptor gene polymorphism predicts long-term changes in body weight. Int. J. Obes. (Lond.)29(5), 458–462 (2005).
   PubMed Web of Science ®Google Scholar
• ParvezB , ChopraN , RowanSet al.A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation. J. Am. Coll. Cardiol.59(1), 49–56 (2012).
   PubMed Web of Science ®Google Scholar
• RosesAD. Pharmacogenetics and the practice of medicine. Nature405(6788), 857–865 (2000).
   PubMed Web of Science ®Google Scholar
• JohnsonM. The β-adrenoceptor. Am. J. Respir. Crit. Care Med.158(Suppl. 2), S146–S153 (1998).
   PubMedGoogle Scholar
• DornGW. Adrenergic signaling polymorphisms and their impact on cardiovascular disease. Physiol. Rev.90(3), 1013–1062 (2010).
   PubMed Web of Science ®Google Scholar
• ShinJ , JohnsonJA. Pharmacogenetics of β‐Blockers. Pharmacotherapy27(6), 874–887 (2007).
   PubMed Web of Science ®Google Scholar
• ThomasCD , JohnsonJA. Pharmacogenetic factors affecting β-blocker metabolism and response. Expert Opin. Drug Metab. Toxicol.16(10), 953–964 (2020).
   PubMed Web of Science ®Google Scholar
• BruckH , LeineweberK , TemmeTet al.The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity. J. Am. Coll. Cardiol.46(11), 2111–2115 (2005).
   PubMed Web of Science ®Google Scholar
• DeGroote P , HelbecqueN , LamblinNet al.Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure. Pharmacogenet. Genomics15(3), 137–142 (2005).
   PubMed Web of Science ®Google Scholar
• ZauggM , BestmannL , WackerJet al.Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology107(1), 33–44 (2007).
   PubMed Web of Science ®Google Scholar
• SuonsyrjäT , DonnerK , Hannila-HandelbergT , FodstadH , KontulaK , HiltunenTP. Common genetic variation of β1-and β2-adrenergic receptor and response to four classes of antihypertensive treatment. Pharmacogenet. Genomics20(5), 342–345 (2010).
   PubMed Web of Science ®Google Scholar
• RauT , DüngenHD , EdelmannFet al.Impact of the β1‐Adrenoceptor Arg389Gly Polymorphism on Heart‐Rate Responses to Bisoprolol and Carvedilol in Heart‐Failure Patients. Clin. Pharmacol. Ther.92(1), 21–28 (2012).
   PubMed Web of Science ®Google Scholar
• LeeH-Y , ChungW-J , JeonH-Ket al.Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study. Korean J. Intern. Med.31(2), 277 (2016).
   PubMed Web of Science ®Google Scholar
• ZengW , ChuTTW , HoCSet al.Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension. Front Cardiovasc Med9, 842875 (2022).
   PubMed Web of Science ®Google Scholar
• O'shaughnessyKM , FuB , DickersonC , ThurstonD , BrownMJ. The gain-of-function G389R variant of the β1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects. Clin. Sci.99(3), 233–238 (2000).
   PubMed Web of Science ®Google Scholar
• FilighedduF , ReidJE , TroffaCet al.Genetic polymorphisms of the β-adrenergic system: association with essential hypertension and response to β-blockade. Pharmacogenomics J.4(3), 154–160 (2004).
   PubMed Web of Science ®Google Scholar
• KarlssonJ , LindL , HallbergPet al.Beta1‐adrenergic receptor gene polymorphisms and response to beta1‐adrenergic receptor blockade in patients with essential hypertension. Clin. Cardiol.27(6), 347–350 (2004).
   PubMed Web of Science ®Google Scholar
• KumarKNM , RamuP , RajanS , ShewadeDG , BalachanderJ , AdithanC. Genetic polymorphisms of β1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population. J. Cardiovasc. Pharmacol.52(5), 459–466 (2008).
   PubMed Web of Science ®Google Scholar
• ChenL , XiaoT , ChenL , XieS , DengM , WuD. The association of ADRB1 and CYP2D6 polymorphisms with antihypertensive effects and analysis of their contribution to hypertension risk. Am. J. Med. Sci.355(3), 235–239 (2018).
   PubMed Web of Science ®Google Scholar
• HuntgeburthM , LaRosée K , TenFreyhaus Het al.The Arg389Gly β1-adrenoceptor gene polymorphism influences the acute effects of β-adrenoceptor blockade on contractility in the human heart. Clin. Res. Cardiol.100(8), 641–647 (2011).
   PubMed Web of Science ®Google Scholar
• SofoworaG , DishyV , MuszkatMet al.A common β1‐adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β‐blockade. Clin. Pharmacol. Ther.73(4), 366–371 (2003).
   PubMed Web of Science ®Google Scholar
• ParikhKS , FiuzatM , DavisGet al.Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes. Circ Genom Precis Med11(8), e002210 (2018).
   PubMed Web of Science ®Google Scholar
• EichhornEJ , DomanskiMJ , Krause-SteinraufH , BristowMR , LavoriPW. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N. Engl. J. Med.344(22), 1659–1667 (2001).
   PubMed Web of Science ®Google Scholar
• O'connorCM , WhellanDJ , LeeKLet al.Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA301(14), 1439–1450 (2009).
   PubMed Web of Science ®Google Scholar
• JohnsonAD , Newton-ChehC , ChasmanDIet al.Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension57(5), 903–910 (2011).
   PubMed Web of Science ®Google Scholar
• HoffmannTJ , EhretGB , NandakumarPet al.Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. Nat. Genet.49(1), 54–64 (2017).
   PubMed Web of Science ®Google Scholar
• SungYJ , WinklerTW , DeLas Fuentes Let al.A large-scale multi-ancestry genome-wide study accounting for smoking behavior identifies multiple significant loci for blood pressure. Am. J. Hum. Genet.102(3), 375–400 (2018).
   PubMed Web of Science ®Google Scholar
• Van DriestS , SleeperL , DietzHet al.Impact of variants in ADRB1 and CYP2C9 on atenolol and losartan response in Marfan syndrome. Presented at: Pediatric Academic Societies 2017 Annual Meeting.CA, USA, 6–9 May 2017.
   Google Scholar
• NedergaardRB , ScottM , WegebergAMet al.Features characterising cardiac autonomic neuropathy in diabetes using ensembled classification. Clin. Neurophysiol. doi:10.1016/j.clinph.2023.06.011 (2023).
   PubMed Web of Science ®Google Scholar
• Oliveira-PaulaGH , PereiraSC , Tanus-SantosJE , LacchiniR. Pharmacogenomics And Hypertension: Current Insights. Pharmgenomics Pers. Med.12, 341–359 (2019).
   PubMed Web of Science ®Google Scholar
• BrownMJ. Personalised medicine for hypertension. BMJ343, d4697 (2011).
   PubMedGoogle Scholar
• TurnerST , SchwartzGL , ChapmanABet al.Plasma renin activity predicts blood pressure responses to β-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. Am. J. Hypertens.23(9), 1014–1022 (2010).
   PubMed Web of Science ®Google Scholar
• ManciaG , GrassiG. Individualization of antihypertensive drug treatment. Diabetes Care36(Suppl. 2), S301–S306 (2013).
   PubMedGoogle Scholar
• MehannaM , WangZ , GongYet al.Plasma renin activity is a predictive biomarker of blood pressure response in European but not in African Americans with uncomplicated hypertension. Am. J. Hypertens.32(7), 668–675 (2019).
   PubMed Web of Science ®Google Scholar